Subsequent cell experiments are imperative to authenticate the involvement of SLC7A3 in the tumorigenesis and progression of breast cancer, while animal experiments are warranted to establish SLC7A3's viability as a therapeutic target for breast cancer. Here, SLC7A3 is linked to breast cancer.